Education
About Us
Working with TipRanks
Follow Us
Autolus Therapeutics Plc (AUTL)
NASDAQ:AUTL
Autolus Therapeutics (AUTL) Ownership Overview
14.07% Mutual Funds
37.46% Other Institutional Investors
0.87% ETFs
47.61% Public Companies and
Individual Investors
The ownership structure of Autolus Therapeutics (AUTL) stock is a mix of institutional, retail, and individual investors. Approximately 52.39% of the company’s stock is owned by Institutional Investors, and 47.61% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 17, 2024 | Martin Pule Chief Scientific Officer | xxxxxxxxxxxxx | $2955674 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $449858 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 20,485,611 | Institution | 7.70% | 38,308,093 | |
| 19,356,365 | Institution | 7.27% | 36,196,403 | |
| 5,481,558 | Institution | 2.06% | 10,250,513 | |
| 4,330,745 | Institution | 1.63% | 8,098,493 | |
| 3,639,000 | Institution | 1.37% | 6,804,930 | |
| 2,266,505 | Institution | 0.85% | 4,238,364 | |
| 1,940,346 | Institution | 0.73% | 3,628,447 | |
| 1,859,779 | Institution | 0.70% | 3,477,787 | |
| 1,327,014 | Institution | 0.50% | 2,481,516 | |
| 1,207,091 | Institution | 0.45% | 2,257,260 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 19,356,365 | Institution | 7.27% | 36,196,403 | |
| 5,481,558 | Institution | 2.06% | 10,250,513 | |
| 2,266,505 | Institution | 0.85% | 4,238,364 | |
| 1,940,346 | Institution | 0.73% | 3,628,447 | |
| 1,859,779 | Institution | 0.70% | 3,477,787 | |
| 1,207,091 | Institution | 0.45% | 2,257,260 | |
| 1,120,733 | Institution | 0.42% | 2,095,771 | |
| 1,005,436 | Institution | 0.38% | 1,880,165 | |
| 889,962 | Institution | 0.33% | 1,664,229 | |
| 879,930 | Institution | 0.33% | 1,645,469 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,131,507 | Institution | 0.43% | 2,115,918 | |
| 307,065 | Institution | 0.12% | 678,614 | |
| 203,117 | Institution | 0.08% | 379,829 | |
| 186,189 | Institution | 0.07% | 348,173 | |
| 110,428 | Institution | 0.04% | 208,709 | |
| 97,143 | Institution | 0.04% | 183,600 | |
| 90,787 | Institution | 0.03% | 385,845 | |
| 70,854 | Institution | 0.03% | 133,914 | |
| 39,347 | Institution | 0.01% | 74,366 | |
| 30,282 | Institution | 0.01% | 56,627 |
FAQ
Who Owns Autolus Therapeutics Plc (AUTL)?
Currently, no data Available
What percentage of Autolus Therapeutics Plc (AUTL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 37.46% of Autolus Therapeutics Plc (AUTL) stock is held by institutional investors.
What percentage of Autolus Therapeutics Plc (AUTL) stock is held by retail investors?
According to the latest TipRanks data, approximately 47.61% of Autolus Therapeutics Plc (AUTL) stock is held by retail investors.
Who owns the most shares of Autolus Therapeutics Plc (AUTL)?
Stephen A. Schwarzman owns the most shares of Autolus Therapeutics Plc (AUTL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.